{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:41:31Z","timestamp":1791261691714,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.beem.2009.06.006","type":"journal-article","created":{"date-parts":[[2009,11,27]],"date-time":"2009-11-27T13:44:35Z","timestamp":1259329475000},"page":"781-792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":193,"title":["Conditions and drugs interfering with thyroxine absorption"],"prefix":"10.1016","volume":"23","author":[{"given":"Llanyee","family":"Liwanpo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome M.","family":"Hershman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2009.06.006_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/thy.1995.5.249","article-title":"Delayed intestinal absorption of levothyroxine","volume":"5","author":"Benvenga","year":"1995","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2009.06.006_bib2","doi-asserted-by":"crossref","first-page":"941","DOI":"10.7326\/0003-4819-90-6-941","article-title":"Malabsorption of thyroid hormones after jejunoileal bypass for obesity","volume":"90","author":"Azizi","year":"1979","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.beem.2009.06.006_bib3","first-page":"765","article-title":"Increased requirement for thyroid hormone after a jejunoileal bypass operation","volume":"123","author":"Topliss","year":"1980","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.beem.2009.06.006_bib4","first-page":"245","article-title":"Thyroxine malabsorption following intestinal bypass surgery","volume":"10","author":"Bevan","year":"1986","journal-title":"International Journal of Obesity"},{"key":"10.1016\/j.beem.2009.06.006_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1210\/jcem-59-1-139","article-title":"L-thyroxine absorption in patients with short bowel","volume":"59","author":"Stone","year":"1984","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.06.006_bib6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2265.1977.tb02022.x","article-title":"Decreased serum thyroid hormone levels and increased TSH response to TRH in infants with celiac disease","volume":"6","author":"Vanderschueren-Lodeweyckx","year":"1977","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.beem.2009.06.006_bib7","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1345\/aph.1A031","article-title":"Exaggerated levothyroxine malabsorption due to calcium carbonate supplementation in gastrointestinal disorders","volume":"35","author":"Csako","year":"2001","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1016\/j.beem.2009.06.006_bib8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1210\/jcem-28-6-749","article-title":"Absorption of oral thyroxine in man","volume":"28","author":"Hays","year":"1968","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.06.006_bib9","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1210\/jcem-30-6-798","article-title":"Absorption of oral thyroxine in hypothyroid and normal man","volume":"30","author":"Read","year":"1970","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.06.006_bib10","first-page":"483","article-title":"The bioavailability thyroxine and 3,5,3\u2032-triiodothyronine in normal subjects and in hyper- and hypothyroid patients","volume":"110","author":"Hasselstr\u00f6m","year":"1985","journal-title":"Acta Endocrinologica (Copenh)"},{"key":"10.1016\/j.beem.2009.06.006_bib11","series-title":"Hormone drugs: proceedings of the FDA-USP workshop on drug and reference standards for insulins, somatropins, and thyroid-axis hormones","first-page":"534","article-title":"Non-isotopic method for determination of oral thyroxine absorption","author":"Greenstadt","year":"1982"},{"key":"10.1016\/j.beem.2009.06.006_bib12","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1172\/JCI106835","article-title":"Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man","volume":"51","author":"Nicoloff","year":"1972","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.beem.2009.06.006_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0026-0495(77)90121-4","article-title":"Aspects of the absorption of oral L-thyroxine in normal man","volume":"26","author":"Wenzel","year":"1977","journal-title":"Metabolism"},{"key":"10.1016\/j.beem.2009.06.006_bib14","first-page":"857","article-title":"Evidence for a clinically important adverse effect of fiber-enriched diet on the bioavailability of levothyroxine in adult hypothyroid patients","volume":"81","author":"Liel","year":"1996","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2009.06.006_bib15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1089\/thy.1998.8.667","article-title":"Effects of pharmacological fiber supplements on levothyroxine absorption","volume":"8","author":"Chiu","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2009.06.006_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/thy.2007.0222","article-title":"Altered intestinal absorption of L-thyroxine caused by coffee","volume":"18","author":"Benvenga","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2009.06.006_bib17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1089\/105072502320288519","article-title":"Gluten-induced enteropathy (coeliac disease) revealed by resistance to treatment with levothyroxine and alfacalcidol in a sixty-eight-year-old patient: a case report","volume":"12","author":"D'Est\u00e8ve-Bonetti","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2009.06.006_bib18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1590\/S0004-27302005000400020","article-title":"Autoimmune hypothyroidism nonresponsive to high doses of levothyroxine and severe hypocalcemia","volume":"49","author":"Silva","year":"2005","journal-title":"Arquivos Brasileiros de Endocrinologia e Metabologia"},{"key":"10.1016\/j.beem.2009.06.006_bib19","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/BF03347379","article-title":"Occurrence of overt celiac disease in the elderly following total thyroidectomy","volume":"29","author":"Caputo","year":"2006","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/j.beem.2009.06.006_bib20","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1089\/thy.2005.15.386","article-title":"Celiac disease presenting as resistant hypothyroidism","volume":"15","author":"McDermott","year":"2005","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2009.06.006_bib21","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1089\/thy.2006.16.1171","article-title":"Lactose intolerance revealed by severe resistance to treatment with levothyroxine","volume":"16","author":"Mu\u00f1oz-Torres","year":"2006","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2009.06.006_bib22","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa043903","article-title":"Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis","volume":"354","author":"Centanni","year":"2006","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2009.06.006_bib23","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/jps.2600630714","article-title":"Effects of colestipol hydrochloride on drug absorption in the rat. I. Aspirin, L-thyroxine, phenobarbital, cortisone, and sulfadiazine","volume":"63","author":"Phillips","year":"1974","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.beem.2009.06.006_bib24","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1001\/jama.1969.03160100047012","article-title":"The influence of cholestyramine on thyroxine absorption","volume":"208","author":"Northcutt","year":"1969","journal-title":"The Journal of the American Medical Association"},{"key":"10.1016\/j.beem.2009.06.006_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/thy.2008.0312","article-title":"Colesevelam hydrochloride and lanthanum carbonate interfere with the absorption of levothyroxine","volume":"19","author":"Weitzman","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2009.06.006_bib26","unstructured":"Daiichi Sankyo, Inc. Welchol(r) prescribing information. Available from: www. Welchol.com\/pdf\/Welchol_PI.pdf."},{"key":"10.1016\/j.beem.2009.06.006_bib27","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.7326\/0003-4819-117-12-1010","article-title":"Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism","volume":"117","author":"Campbell","year":"1992","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.beem.2009.06.006_bib28","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00007611-199706000-00011","article-title":"Ferrous sulfate-induced increase in requirement for thyroxine in a patient with primary hypothyroidism","volume":"90","author":"Shakir","year":"1997","journal-title":"Southern Medical Journal"},{"key":"10.1016\/j.beem.2009.06.006_bib29","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0002-9343(94)90093-0","article-title":"Sucralfate causes malabsorption of L-thyroxine","volume":"90","author":"Sherman","year":"1994","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.beem.2009.06.006_bib30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.7326\/0003-4819-117-5-445_3","article-title":"Levothyroxine binding by sucralfate","volume":"117","author":"Havrankova","year":"1992","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.beem.2009.06.006_bib31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.7326\/0003-4819-121-2-199407150-00024","article-title":"Sucralfate and the absorption of L-thyroxine","volume":"121","author":"Campbell","year":"1994","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.beem.2009.06.006_bib32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/archinte.1992.00400130181024","article-title":"Evidence for interference with the intestinal absorption of levothyroxine sodium by aluminum hydroxide","volume":"152","author":"Sperber","year":"1992","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.beem.2009.06.006_bib33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9343(94)90303-4","article-title":"Nonspecific intestinal adsorption of levothyroxine by aluminum hydroxide","volume":"97","author":"Liel","year":"1994","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.beem.2009.06.006_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-0773.1999.tb00883.x","article-title":"Intestinal adsorption of levothyroxine by antacids and laxatives: case stories and in vitro experiments","volume":"84","author":"Mersebach","year":"1999","journal-title":"Pharmacology & Toxicology"},{"key":"10.1016\/j.beem.2009.06.006_bib35","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jama.279.10.750-b","article-title":"Calcium carbonate and reduction of levothyroxine efficacy","volume":"279","author":"Schneyer","year":"1998","journal-title":"The Journal of the American Medical Association"},{"key":"10.1016\/j.beem.2009.06.006_bib36","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1001\/jama.283.21.2822","article-title":"Effect of calcium carbonate on the absorption of levothyroxine","volume":"283","author":"Singh","year":"2000","journal-title":"The Journal of the American Medical Association"},{"key":"10.1016\/j.beem.2009.06.006_bib37","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1089\/105072501753211046","article-title":"The acute effect of calcium carbonate on the intestinal absorption of levothyroxine","volume":"11","author":"Singh","year":"2001","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2009.06.006_bib38","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11255-006-9166-6","article-title":"Effect of phosphate binders upon TSH and L-thyroxine dose in patients on thyroid replacement","volume":"39","author":"Diskin","year":"2007","journal-title":"International Urology and Nephrology"},{"key":"10.1016\/j.beem.2009.06.006_bib39","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1089\/thy.2007.0060","article-title":"New medications which decrease levothyroxine absorption","volume":"17","author":"John-Kalarickal","year":"2007","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2009.06.006_bib40","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/archinte.163.11.1367","article-title":"Raloxifene causing malabsorption of levothyroxine","volume":"163","author":"Siraj","year":"2003","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.beem.2009.06.006_bib41","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1592\/phco.26.6.881","article-title":"Increased thyroid-stimulating hormone levels associated with concomitant administration of levothyroxine and raloxifene","volume":"26","author":"Garwood","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.beem.2009.06.006_bib42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4158\/EP.13.4.345","article-title":"Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism","volume":"13","author":"Sachmechi","year":"2007","journal-title":"Endocrine Practice"},{"key":"10.1016\/j.beem.2009.06.006_bib43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2006-924980","article-title":"Absorption kinetics of levothyroxine is not altered by proton-pump inhibitor therapy","volume":"38","author":"Dietrich","year":"2006","journal-title":"Hormone and Metabolic Research"},{"key":"10.1016\/j.beem.2009.06.006_bib44","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/thy.2007.0381","article-title":"The effect of famotidine, esomeprazole, and ezetimibe on levothyroxine absorption","volume":"18","author":"Ananthakrishnan","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2009.06.006_bib45","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.clon.2005.05.001","article-title":"Hypothyroidism in thyroid carcinoma follow-up: orlistat may inhibit the absorption of thyroxine","volume":"17","author":"Madhava","year":"2005","journal-title":"Clinical Oncology (Royal College of Radiologists (Great Britain))"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X09000761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X09000761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:42:04Z","timestamp":1761496924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X09000761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1521690X09000761"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2009.06.006","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conditions and drugs interfering with thyroxine absorption","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2009.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}